Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis.

Autor: Palavani LB; Max Planck University Center, Indaiatuba, São Paulo, SP, Brazil., Camerotte R; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Vieira Nogueira B; Serra dos Órgãos University Center, Teresópolis, RJ, Brazil. Electronic address: bevnogueira@gmail.com., Ferreira MY; Department of Neurosurgery, Lenox Hill Hospital/Northwell Health, New York, NY, USA., Oliveira LB; Department of Neurosurgery, State University of Ponta Grossa, Ponta Grossa, PR, Brazil., Pari Mitre L; Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil., Coelho Nogueira de Castro W; State University of Piauí, Teresina, PI, Brazil., Canto Gomes GL; Federal University of Amazonas, Manaus, AM, Brazil., Fabrini Paleare LF; School of Medicine, Pontifical Catholic University of Paraná, Curitiba, PR, Brazil., Batista S; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Fim Andreão F; Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Bertani R; Department of Neurosurgery, University of São Paulo, São Paulo, SP, Brazil., Dias Polverini A; Neurosurgical Oncology Division, Barretos Cancer Hospital, Barretos, SP, Brazil.

Publikováno v: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2024 Oct; Vol. 128, pp. 110774. Date of Electronic Publication: 2024 Aug 10.